In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins

Lysosomal storage diseases arise from a genetic loss-of-function defect in enzymes mediating key catabolic steps resulting in accumulation of substrate within the lysosome. Treatment of several of these disorders has been achieved by enzyme replacement therapy (ERT), in which a recombinant version o...

Ausführliche Beschreibung